🔎 Trials Near Me

Akèy › Ensifizyans kadyak › Oklahoma › Oklahoma City

Etid klinik pou Ensifizyans kadyak nan Oklahoma City, OK

7 etid pou Ensifizyans kadyak ap chèche patisipan nan sit nan ak bò kote Oklahoma City (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF

Ap rekriteFaz 3
  • Research Site, Oklahoma City
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07761117

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

Ap rekriteFaz 3
  • South Oklahoma Heart Research, Oklahoma City
Laj 18 a 99 · Tout sèks · Mizajou Sep 16, 2026 · NCT07037459

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

Ap rekriteFaz 3
  • Research Site, Oklahoma City
  • Research Site, Oklahoma City
Laj 40 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT06677060

Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure

Ap rekrite
  • Oklahoma Cardiovascular Research Group, Oklahoma City
Laj 21 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT05677100

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

Ap rekriteEtid obsèvasyon
  • Oklahoma City, Oklahoma City
Tout laj · Tout sèks · Mizajou Aug 20, 2026 · NCT00271180

Alleviant ALLAY-HF Study

Ap rekrite
  • South Oklahoma Heart Research, LLC., Oklahoma City
Laj 40 ak plis · Tout sèks · Mizajou Aug 14, 2026 · NCT05685303

Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

Ap rekrite
  • Integris Baptist Medical Center, Oklahoma City
Laj 18 ak plis · Tout sèks · Mizajou Jun 10, 2026 · NCT06526195

Etid Ensifizyans kadyak nan lòt vil

Lòt etid nan Oklahoma City

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.